Seahorse Licenses IP for Cellular Bioenergetics Research
August 21, 2012
Seahorse Licenses IP for Cellular Bioenergetics Research
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Oxford Immunotec, Lophius Ink Licensing Deals for Development of T-cell-based Assays
January 29, 2013 / GenomeWeb Daily News - Castle Bio Licenses IP from Brigham and Women's Hospital for Mesothelioma Test
September 12, 2012 / GenomeWeb Daily News - HTG Licenses Merck's Breast Cancer Biomarker Patent Portfolio
July 11, 2012 / GenomeWeb Daily News - PCR Licensing Deal Validates Roche IP; Bolsters Life Tech's Ongoing Push into IVD Market
February 23, 2012 / PCR Insider - TrovaGene Regains Ownership, Patent Control of Transrenal Technology
August 10, 2011 / GenomeWeb Daily News